Revolutionary nanotechnology platform for traumatic brain injury, dementia, Alzheimer's disease, and neuroinflammatory conditions with neuroprotective salsalate formulations
Comprehensive nanoformulated platform addressing critical unmet needs in neurological and neurodegenerative diseases
Advanced neuroprotective formulations targeting acute neuroinflammation and secondary injury cascades in TBI patients.
Targeted therapeutic approach for neurodegenerative diseases focusing on neuroinflammation and cognitive preservation.
Broad-spectrum anti-inflammatory platform for various neuroinflammatory conditions and chronic brain inflammation.
Preventive and therapeutic interventions for age-related cognitive decline and memory disorders.
Our proprietary nanotechnology platform enables unprecedented access to the central nervous system through advanced formulations that cross the blood-brain barrier effectively.
By utilizing specialized nanoparticles, we deliver salsalate directly to brain tissue, achieving therapeutic concentrations while minimizing systemic exposure and side effects.
This revolutionary approach addresses the fundamental challenge in neurological therapeutics: getting effective treatments past the blood-brain barrier to reach target tissues in the brain and CNS.
Engineered nanoparticles cross the blood-brain barrier efficiently
Precise localization to affected brain regions
Anti-inflammatory and neuroprotective effects
Controlled release for prolonged therapeutic effect
Targeting major neurological conditions affecting millions worldwide
Traumatic brain injuries require immediate neuroprotective intervention to prevent long-term disability
Growing population needs innovative treatments to slow disease progression and preserve cognition
Neurological disorders represent enormous healthcare burden requiring cost-effective solutions
Blood-brain barrier represents major obstacle requiring innovative delivery approaches
Comprehensive development program advancing neurological therapeutics from research to clinical application
Advanced in vitro and in vivo studies demonstrating effective BBB penetration of nanoformulated salsalate with therapeutic brain tissue concentrations.
Comprehensive efficacy studies in established TBI models showing significant neuroprotection and improved functional outcomes with nanotechnology platform.
Investigation of anti-neuroinflammatory effects in transgenic Alzheimer's models with focus on amyloid reduction and cognitive preservation.
Planned Phase I safety studies for TBI indication followed by efficacy trials in multiple neurological conditions based on preclinical success.
Partner with us to develop breakthrough treatments for TBI, dementia, and neurological disorders. Join leading researchers and clinicians in transforming brain health through innovative nanotechnology.